Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Janssen joins vax parade

Posted 19 November 2020

The TGA has granted Janssen a provisional determination for its viral vector vaccine against COVID-19, Ad26.COV2.S.

The Janssen product joins Pfizer's mRNA and AstraZeneca's viral vector vaccines on the provisional determinations list.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Picking the path out of Covid
Now is not the time for leaders to play it safe
Special Report
Aust Covid Vaccine Tracker
UPDATE: Gilead hits back at WHO over remdesivir
Approvals Action
Trio of new drugs on ARTG
Roche, Seqirus, Clinuvel enlarge local portfolios